Impact of an evidence-based bundle on incontinence-associated dermatitis prevalence in hospital patients: A quasi-experimental translational study.
faecal incontinence
irritant dermatitis
pressure ulcer
prevalence
urinary incontinence
Journal
International wound journal
ISSN: 1742-481X
Titre abrégé: Int Wound J
Pays: England
ID NLM: 101230907
Informations de publication
Date de publication:
Jun 2024
Jun 2024
Historique:
revised:
10
05
2024
received:
15
12
2023
accepted:
14
05
2024
medline:
20
6
2024
pubmed:
20
6
2024
entrez:
20
6
2024
Statut:
ppublish
Résumé
The study aimed to evaluate the effect of an intervention on the prevalence and severity of incontinence-associated dermatitis (IAD) in six hospitals in one state in Australia. This quasi-experimental pre-and post-study, conducted in 18 wards, was part of a larger implementation science study on incontinence-associated dermatitis. Skin and incontinence assessments were conducted on patients during February and March 2020 (pre-intervention) and July and August 2021 (post-intervention). The intervention comprised continence assessment and management, an education brochure for patients, family and caregivers on IAD, the Ghent Global IAD Categorisation Tool (GLOBIAD) and a skin care regime with patient skin protection measures (three-in-one barrier cream cloths, minimisation of bed protection layers, use of appropriate continence aid). A total of 1897 patients were assessed (pre-intervention = 964, post-intervention = 933). A total of 343 (35.6%) pre-intervention patients and 351 (37.6%) post-intervention patients had incontinence. The prevalence of hospital-acquired IAD was 6.71% in the pre-intervention group and 4.27% in the post-intervention group; a reduction of 36.3% (p = 0.159) despite higher patient acuity, prevalence of double incontinence and the COVID-19 pandemic in the post-intervention group compared with the pre-intervention group. Our multisite best practice IAD prevention and treatment intervention was able to reduce the prevalence and severity of hospital-acquired IAD, suggesting enduring effectiveness of the intervention.
Types de publication
Journal Article
Multicenter Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
e14936Subventions
Organisme : New South Wales Ministry of Health Translational Research Grant Scheme
ID : H19/53776
Informations de copyright
© 2024 The Author(s). International Wound Journal published by Medicalhelplines.com Inc and John Wiley & Sons Ltd.
Références
Kayser SA, Phipps L, VanGilder CA, Lachenbruch C. Examining prevalence and risk factors of incontinence‐associated dermatitis using the international pressure ulcer prevalence survey. J Wound Ostomy Cont Nurs. 2019;46(4):285‐290.
Johansen E, Bakken LN, Duvaland E, et al. Incontinence‐associated dermatitis (IAD): prevalence and associated factors in 4 hospitals in Southeast Norway. J Wound Ostomy Cont Nurs. 2018;45(6):527‐531.
Barakat‐Johnson M, Barnett C, Lai M, Wand T, White K. Incontinence, incontinence‐associated dermatitis, and pressure injuries in a Health District in Australia: a mixed‐methods study. J Wound Ostomy Cont Nurs. 2018;45(4):349‐355.
Gray M, Giuliano KK. Incontinence‐associated dermatitis, characteristics and relationship to pressure injury: a multisite epidemiologic analysis. J Wound Ostomy Continence Nurs. 2018;45(1):63‐67.
Wei M, Yang D, Wu L, Chen W, Chen Y, Fu Q. The prevalence of incontinence‐associated dermatitis in hospitalized patients in China: a systematic review and meta‐analysis. Adv Skin Wound Care. 2020;33(10):1‐7.
Yüceler Kaçmaz H, Kaplan Ö, Kaplan A, Şahin MG, Cetinkaya A, Avci A. Incontinence‐associated dermatitis: prevalence in intensive care units and knowledge, attitudes, and practices of nurses. J Nurs Care Qual. 2023;38(4):354‐360.
de Castro DLV, da Silva EL, Onaga LS, Nogueira PC, Furlan PC, de Gouveia Santos VLC. The prevalence of skin lesions and associated factors in hospitalised adult patients with cancer. J Wound Care. 2022;31(8):660‐668.
Grden CRB, Martins AR, Cabral LPA, et al. Incontinence associated dermatitis in elderly people admitted to a university hospital. Rev Bras Enferm. 2020;73(Suppl 3):e20190374.
Borges EL, Moraes JT, Otoni Spira JA, et al. Prevalence and Management of Urinary Incontinence in a Brazilian hospital: a prospective, descriptive study. Wound Manag Prev. 2019;65(12):12‐20.
Hödl M, Blanař V, Amir Y, Lohrmann C. Association between incontinence, incontinence‐associated dermatitis and pressure injuries: a multisite study among hospitalised patients 65 years or older. Australas J Dermatol. 2020;61(1):e144‐e146.
Beeckman D. A decade of research on incontinence‐associated dermatitis (IAD): evidence, knowledge gaps and next steps. J Tissue Viability. 2017;26(1):47‐56.
Beeckman D, Smet S, van den Bussche K. Incontinence‐associated dermatitis: why do we need a core outcome set for clinical research? Wounds Int. 2018;9(2):21‐25.
Barakat‐Johnson M, Lai M, Basjarahil S, et al. “I feel like a baby wearing a nappy…It's embarrassing”: a qualitative study of patients' experience of incontinence and incontinence‐associated dermatitis in hospital settings. J Wound Care. 2024; In press.
Beeckman D, Campbell J, Campbell K, et al. Incontinence‐associated dermatitis: moving prevention forward. Wounds Int. 2015.
European Pressure Ulcer Advisory Panel. National Pressure Injury Advisory Panel and Pan Pacific Pressure Injury Alliance. Prevention and Treatment of Pressure Ulcers/Injuries: Clinical Practice Guideline. The International Guideline. 2019.
World Health Organization. EK02.22 Irritant contact dermatitis due to incontinence 2023. Available from: https://icd.who.int/browse/2024-01/mms/en#/http://id.who.int/icd/entity/326384712
McNichol L, Bliss DZ, Gray M. Moisture‐associated skin damage: expanding practice based on the newest ICD‐10‐CM codes for irritant contact dermatitis associated with digestive secretions and fecal or urinary effluent from an abdominal stoma or enterocutaneous fistula. J Wound Ostomy Continence Nurs. 2022;49(3):235‐239.
Gray M, Bliss DZ, McNichol L. Moisture‐associated skin damage: expanding and updating practice based on the newest ICD‐10‐CM codes. J Wound Ostomy Continence Nurs. 2022;49(2):143‐151.
Bliss DZ, McNichol L, Cartwright D, Gray M. Practice alert: new ICD‐10 codes for MASD. J Wound Ostomy Continence Nurs. 2022;49(1):15‐19.
Barakat‐Johnson M, Basjarahil S, Campbell J, et al. Implementing best available evidence into practice for incontinence‐associated dermatitis in Australia: a multisite multimethod study protocol. J Tissue Viability. 2020;30:67‐77.
Kitson A, Harvey G, McCormack B. Enabling the implementation of evidence based practice: a conceptual framework. Qual Health Care. 1998;7(3):149‐158.
Schulz KF, Altman DG, Moher D. The CG. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMC Med. 2010;8(1):18.
Hoffmann TC, Glasziou PP, Boutron I, et al. Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide. Br Med J. 2014;348:g1687.
Beeckman D, van den Bussche K, Alves P, et al. The Ghent Global IAD Categorisation Tool (GLOBIAD). Skin Integrity Research Group ‐ Ghent University; 2017.
Barakat‐Johnson M, Lai M, Barnett C, et al. Hospital‐acquired pressure injuries: are they accurately reported? A prospective descriptive study in a large tertiary hospital in Australia. J Tissue Viability. 2018;27(4):203‐210.
Parliament of Australia. COVID‐19: a chronology of state and territory government announcements (up until 30 June 2020). https://www.aph.gov.au/About_Parliament/Parliamentary_departments/Parliamentary_Library/pubs/rp/rp2021/Chronologies/COVID‐19StateTerritoryGovernmentAnnouncements
Barakat‐Johnson M, Lai M, Wand T, Coyer F, White K. Cultivating incontinence‐associated dermatitis prevention practices in an Australian local Health District: a quasi‐experimental study. Ostomy Wound Manage. 2018;64(12):16‐28.
Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)—a metadata‐driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377‐381.
The National Health and Medical Research Council, Australian Research Council, Universities Australia. National Statement on Ethical Conduct in Human Research (Updated 2018). Commonwealth of Australia; 2007.
IBM Corp. IBM SPSS Statistics for Windows, Version 26.0. IBM Corp; 2019.
Peduzzi P, Concato J, Kemper E, Holford TR, Feinstein AR. A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol. 1996;49(12):1373‐1379.
Zhang X, Wang X, Zhao X, Zhang Y. A structured skin care protocol for preventing and treating incontinence‐associated dermatitis in critically ill patients. Adv Skin Wound Care. 2022;35(6):335‐342.
Glass GF Jr, Goh CCK, Cheong RQ, Ong ZL, Khong PCB, Chan EY. Effectiveness of skin cleanser and protectant regimen on incontinence‐associated dermatitis outcomes in acute care patients: a cluster randomised trial. Int Wound J. 2021;18(6):862‐873.
Kon Y, Ichikawa‐Shigeta Y, Iuchi T, et al. Effects of a skin barrier cream on management of incontinence‐associated dermatitis in older women: a cluster randomized controlled trial. J Wound Ostomy Continence Nurs. 2017;44(5):481‐486.
Coyer F, Gardner A, Doubrovsky A. An interventional skin care protocol (InSPiRE) to reduce incontinence‐associated dermatitis in critically ill patients in the intensive care unit: a before and after study. Intensive Crit Care Nurs. 2017;40:1‐10.
Beeckman D, van Damme N, Schoonhoven L, et al. Interventions for preventing and treating incontinence‐associated dermatitis in adults. Cochrane Database Syst Rev. 2016;11(11):Cd011627.